Sangamo Therapeutics shares are trading lower after the company announced the pricing of a $24.0 million registered direct offering.
Portfolio Pulse from Benzinga Newsdesk
Sangamo Therapeutics' stock is trading lower following the announcement of a $24.0 million registered direct offering.
March 22, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Sangamo Therapeutics' shares are trading lower due to the announcement of a $24.0 million registered direct offering.
The announcement of a registered direct offering often leads to a decrease in stock price in the short term due to the dilution of existing shares. Given the size of the offering relative to Sangamo's market cap, this news is likely to have a significant negative impact on the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100